^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Tempus HLA-LOH assay

    Company:
    Tempus
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    Tempus HLA-LOH test is intended to identify cancer patients with solid tumors who may benefit from treatment with specific targeted therapies when tumor has experienced allele-specific loss of heterozygosity (LOH) for specific human leukocyte antigen (HLA) Class I alleles.
    Cancer:
    Solid Tumor
    Method:
    Machine learning model